Pre-Approval Information Exchange Act of 2022
Latest action · Nov 16, 2022 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedNov 15, 2022
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Pre-Approval Information Exchange Act of 2022
This bill specifies that product information that is exchanged between drug manufacturers and certain health care entities (e.g., formulary committees) about drug products before regulatory approval is not considered to be misbranding if it relates to the product's investigational use and meets other specified criteria. The Government Accountability Office must study the use and effects of such information.
Cosponsors 5
Members who signed on, in the order they did. All signed on Nov 15, 2022.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CA | Anna G. Eshoo | Original | Nov 15, 2022 |
| D-CA | Doris O. Matsui | Original | Nov 15, 2022 |
| R-VA | H. Morgan Griffith | Original | Nov 15, 2022 |
| R-TX | Michael C. Burgess | Original | Nov 15, 2022 |
| D-CA | Scott H. Peters | Original | Nov 15, 2022 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Nov 15, 2022 |
| Health Subcommittee | Referred Nov 16, 2022 |
Actions 3
Everything that happened, newest first.
- Nov 16, 2022Referred to the Subcommittee on Health.
- Nov 15, 2022Introduced in House
- Nov 15, 2022Referred to the House Committee on Energy and Commerce.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Lists H8508H.R. 9297–9304 | — | Nov 15, 2022 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 7667 | Food and Drug Amendments of 2022 | Related bill | Jun 9, 2022 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to facilitate the exchange of certain product information, and for other purposes.
- Short Title(s) as Introduced
- Pre-Approval Information Exchange Act of 2022
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Nov 15, 2022Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
